|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on November 22, 2004
Accepted on April 22, 2005
Lipids, Lipoproteins, and Cardiovascular Risk Factors |
-Glutamyltransferase Was Differently Associated with Microalbuminuria by Status of Hypertension or Diabetes: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
1 Department of Preventive Medicine, School of Medicine, Kyungpook National University, Daegu, Korea, and Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN
2 Division of Epidemiology, School of Public Health, and Department of Nutrition, University of Oslo, Oslo, Norway
3 Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
* To whom correspondence should be addressed. E-mail: jacobs{at}epi.umn.edu.
Background: We hypothesized that serum
-glutamyltransferase (GGT) would positively predict the risk of microalbuminuria, a frequent consequence of both diabetes and hypertension, because serum GGT predicted diabetes and hypertension in dose-response relationships.
Methods: In this prospective study, 2478 black and white men and women at year 10 without microalbuminuria provided urine samples 5 years later. Year 10 GGT cutpoints were 12, 18, and 29 U/L.
Results: The incidence of microalbuminuria across year 10 GGT categories was U-shaped. Adjusted odds ratios across quartiles of serum GGT were 1.0, 0.39, 0.54, and 0.94 (P <0.01 for quadratic term), but the shape of association depended on the status of hypertension or diabetes (P <0.01 for interaction). Among individuals who ever had hypertension or diabetes, year 10 serum GGT showed a clear positive dose-response association with incident microalbuminuria (P <0.01 for trend), whereas among individuals with neither hypertension nor diabetes during the study, year 10 GGT showed a U-shaped association with it (P =0.01 for quadratic term). When the long-term risk was evaluated in 3895 participants based on serum GGT at year 0 and prevalence of microalbuminuria at year 10 or year 15, the trends were similar but weaker than those of short-term incidence risk.
Conclusions: Serum GGT within the physiologic range predicted microalbuminuria among patients with hypertension or diabetes and may act as a predictor of microvascular and/or renal complications in these vulnerable groups. GGT showed a U-shaped association with microalbuminuria among persons who did not develop either hypertension or diabetes.
The following articles in journals at HighWire Press have cited this article:
![]() |
S. M. Grundy Gamma-Glutamyl Transferase: Another Biomarker for Metabolic Syndrome and Cardiovascular Risk Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 4 - 7. [Full Text] [PDF] |
||||
![]() |
D.-H. Lee, K. Silventoinen, G. Hu, D. R. Jacobs Jr, P. Jousilahti, J. Sundvall, and J. Tuomilehto Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28 838 middle-aged men and women Eur. Heart J., September 2, 2006; 27(18): 2170 - 2176. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |